JAMDA
Volume 10, Issue 2 , Pages 120-126 , February 2009

Chronic Kidney Disease, Anemia, and the Association Between Chronic Kidney Disease-Related Anemia and Activities of Daily Living in Older Nursing Home Residents

  • John Schnelle, PhD

      Affiliations

    • Vanderbilt University Medical Center, Nashville, TN
    • Corresponding Author InformationAddress correspondence to John Schnelle, PhD, Center for Quality Aging, 1161 21st Avenue South, S-1121, Medical Center North, Vanderbilt University Medical Center, Nashville, TN 37232-2400
    • ,
  • Dan Osterweil, MD

      Affiliations

    • University of California Los Angeles, Los Angeles, CA
    • ,
  • Denise Globe, PhD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • Angela Sciarra, PharmD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • Paul Audhya, MD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • Arie Barlev, PharmD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA

References 

  1. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278–285
  2. Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol. 1976;31:155–163
  3. Astor BC, Muntner P, Levin A, et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002;162:1401–1408
  4. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20:1501–1510
  5. Li S, Foley RN, Collins AJ. Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease. Int Urol Nephrol. 2005;37:395–402
  6. Holland DC, Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant. 2000;15:650–658
  7. Levin A, Djurdjev O, Duncan J, et al. Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes. Nephrol Dial Transplant. 2006;21:370–377
  8. Klang B, Bjorvell H, Clyne N. Quality of life in predialytic uremic patients. Qual Life Res. 1996;5:109–116
  9. Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int. 2004;66:753–760
  10. Hayashi T, Suzuki A, Shoji T, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis. 2000;35:250–256
  11. Jungers P, Choukroun G, Oualim Z, et al. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant. 2001;16:307–312
  12. Levin A, Djurdjev O, Thompson C, et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis. 2005;46:799–811
  13. Pappas KD, Gouva CD, Katopodis KP, et al. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): Effects on cardiac performance. Cardiovasc Drugs Ther. 2008;22:37–44
  14. Portoles J, Torralbo A, Martin P, et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis. 1997;29:541–548
  15. Abu-Alfa AK, Sloan L, Charytan C, et al. The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis. Curr Med Res Opin. 2008;24:1091–1100
  16. Alexander M, Kewalramani R, Agodoa I, Globe D. Association of anemia correction with health related quality of life in patients not on dialysis. Curr Med Res Opin. 2007;23:2997–3008
  17. Revicki DA, Brown RE, Feeny DH, et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis. 1995;25:548–554
  18. Rhoades JA, Sommers JP. Trends in nursing home expenses, 1987 and 1996. Health Care Financ Rev. 2003;25:99–114
  19. Hawes C, Morris JN, Phillips CD, et al. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist. 1995;35:172–178
  20. Mor V. A comprehensive clinical assessment tool to inform policy and practice: Applications of the minimum data set. Med Care. 2004;42:III50–III59
  21. Snowden M, McCormick W, Russo J, et al. Validity and responsiveness of the Minimum Data Set. J Am Geriatr Soc. 1999;47:1000–1004
  22. Jones A. The National Nursing Home Survey: 1999 summary. Vital Health Stat. 2002;13:1–116
  23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266
  24. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001;10:785–792
  25. World Health Organization (WHO). Nutritional anemia: Report of a WHO scientific group. Technical Report Series, No. 405. Geneva, Switzerland: WHO; 1968;
  26. Bates-Jensen BM, Simmons SF, Schnelle JF, Alessi C. Evaluating the accuracy of minimum data set bed-mobility ratings against independent performance assessments: Systematic error and directions for improvement. Gerontologist. 2005;45:731–738
  27. Efron B, Taibshirani R. An Introduction to the Bootstrap. New York: Chapman & Hall; 1993;
  28. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  29. Robinson B, Artz AS, Culleton B, et al. Prevalence of anemia in the nursing home: Contribution of chronic kidney disease. J Am Geriatr Soc. 2007;55:1566–1570
  30. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–666
  31. Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients: Results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc. 2007;55:1557–1565

 This study was supported by Amgen Inc, Thousand Oaks, CA. John Schnelle, PhD, has served as a consultant for Amgen Inc. Dan Osterweil, MD, has served as a consultant and on the speaker bureau for Amgen Inc and Novartis, as a consultant for SCAN Health Plan, and on the speaker bureau for Forest Laboratories. Denise Globe, PhD, Angela Sciarra, PharmD, and Arie Barlev, PharmD are employees of Amgen Inc. Paul Audhya, MD, was previously employed at Amgen Inc. We would like to thank Yeshi Mikyas, PhD, (Amgen Inc) for providing assistance in writing this manuscript.

PII: S1525-8610(08)00294-6

doi: 10.1016/j.jamda.2008.08.012

JAMDA
Volume 10, Issue 2 , Pages 120-126 , February 2009

Article Tools

* Image Usage & Resolution